Glytec Software Wins "Best Computerized Decision Support Solution" in 2025 MedTech Breakthrough Awards Program

Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies

BOSTON, May 8, 2025 /PRNewswire/ -- Glytec, the Software-as-a-Service (SaaS) technology leader and pioneer in diabetes and insulin management, today announced that their cloud-based Glucommander software solution has been selected as winner of the "Best Computerized Decision Support Solution" award in the ninth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market.

Glytec's FDA-cleared Glucommander software, supported by over 100 patents and over 100 whitepapers, leverages real-time and historical data to personalize insulin dosing by learning each patient's insulin sensitivity and anticipating future needs, helping to improve patient outcomes, save money, and streamline workflows. This intelligent software provides safe, personalized treatment recommendations, adapting to changing patient conditions and continuously learning from a deep, unique pool of clinical data accumulated over years of hospitalizations.

"We directed this powerful software platform to impact the 30 to 50 percent of hospitalized patients that have diabetes or poorly managed blood glucose. By not only reducing human error but also streamlining workflows for healthcare providers, we're allowing them to focus on delivering care rather than managing complex insulin calculations," said Patrick Cua, CEO of Glytec. "Ultimately, we believe that Glytec's impact goes beyond software—it's about improving patient outcomes, enhancing clinician workflows, and ensuring better financial sustainability for healthcare organizations. Thank you to MedTech Breakthrough for recognizing the importance of our work with this wonderful award."

The MedTech Breakthrough Awards program celebrates excellence and innovation in the health and medical technology industry, recognizing the companies, products, and solutions driving meaningful progress and improving patient care. Spanning a wide range of categories—including telehealth, clinical administration, patient engagement, electronic health records (EHR), virtual care, medical devices, medical data and privacy, and beyond—the awards highlight the groundbreaking work that is transforming the healthcare landscape.

This year's program saw a record-breaking number of nominations from leading companies and startups across more than 18 countries, showcasing the global impact and momentum of the digital healthcare industry today.

"Glytec is pioneering the digital health landscape with its innovative software, impact on patients at scale, and enhancing overall quality and safety of care at hundreds of healthcare organizations. The prevalence of diabetes continues to rise, and with the institution of new CMS hypo- and hyperglycemia quality measures, hospitals are evaluating how software can help raise the standard of care and replace complex, manual paper protocols," said Steve Johansson, managing director, MedTech Breakthrough. "By combining cutting-edge software, extensive clinical data, and seamless integration with hospital IT systems, Glytec is making a difference in the management of diabetes and other glycemic-related conditions, delivering results that matter. Congratulations to Glytec for winning 'Best Computerized Decision Support Solution!'"

About Glytec
Glytec's industry-leading SaaS platform, trusted by 350+ hospitals, empowers collaborative diabetes management and insulin dosing—improving patient outcomes, reducing length of stay, and streamlining workflows while delivering a 6-8x ROI. The first-ever FDA-cleared cloud-based insulin management software is EMR-integrated, easy to set up, and validated by over 100 patents and over 100 publications. It's built by a mission-driven team dedicated to helping healthcare leaders, clinicians and patients promote health equity and improve diabetes outcomes from hospital to home.

For more information, follow Glytec on LinkedIn, or visit www.glytec.com.

About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com. 

Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.

Contact Information
Public Relations
[email protected]

SOURCE Glytec, LLC